Table of Contents
Beyond-use dating is a critical aspect of pharmaceutical compounding, ensuring the safety and efficacy of compounded medications. The United States Pharmacopeia (USP) USP 795 provides guidelines and best practices for beyond-use dating, helping pharmacists determine appropriate expiration dates for compounded preparations.
Understanding Beyond-Use Dating
Beyond-use dating refers to the date after which a compounded drug should not be used. It is distinct from the expiration date on commercially manufactured products. The USP 795 guidelines emphasize the importance of establishing beyond-use dates based on the stability of the preparation, the ingredients used, and storage conditions.
Calculating Beyond-Use Dates in USP 795
The calculation of beyond-use dates involves considering various factors, including the preparation type, stability data, and storage conditions. USP 795 categorizes compounded preparations into three types: non-aqueous, aqueous, and creams/ointments/semisolids, each with specific guidelines for beyond-use dating.
1. Non-Aqueous Preparations
For non-aqueous formulations, the beyond-use date is generally not later than 6 months or the earliest expiration date of any ingredient used, whichever is earlier. Stability data should support this timeframe.
2. Aqueous Preparations
For water-based preparations, the maximum beyond-use date is 14 days when stored at controlled cold temperatures, unless stability data suggest a longer period.
3. Topical Preparations (Creams, Ointments, Semisolids)
Topical preparations typically have a beyond-use date of 30 days if stored properly, unless specific stability data support a longer or shorter period.
Best Practices for Ensuring Accurate Beyond-Use Dating
To ensure the safety and effectiveness of compounded medications, pharmacists should adhere to the following best practices:
- Review and utilize stability data from reputable sources.
- Label preparations with clear beyond-use dates based on calculations.
- Store compounds under recommended conditions to maintain stability.
- Document calculations and stability considerations for quality assurance.
- Regularly review and update beyond-use dates as new stability data become available.
Conclusion
Beyond-use dating is a vital component of safe compounding practices as outlined in USP 795. Proper calculations, supported by stability data and adherence to storage guidelines, help pharmacists provide effective and safe medications to patients. Staying informed about best practices ensures compliance and optimal patient care.